SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-007329
Filing Date
2019-04-18
Accepted
2019-04-18 16:03:10
Documents
5
Period of Report
2019-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nc10001083x2_8k.htm 8-K 21206
2 EXHIBIT 1.1 nc10001083x2_ex1-1.htm EX-1.1 287205
3 EXHIBIT 5.1 nc10001083x2_ex5-1.htm EX-5.1 6644
4 nc10001083x2_ex5-1img1.jpg GRAPHIC 89693
5 nc10001083x2_ex5-1img2.jpg GRAPHIC 30438
  Complete submission text file 0001140361-19-007329.txt   481899
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36829 | Film No.: 19755916
SIC: 2834 Pharmaceutical Preparations